{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T08:11:12Z","timestamp":1778227872608,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,3]],"date-time":"2027-02-03T00:00:00Z","timestamp":1801612800000},"content-version":"am","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001422","name":"American Society of Hematology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016532","name":"Johns Hopkins All Children's Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016532","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007880","name":"Johns Hopkins University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005881","name":"Hemostasis and Thrombosis Research Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005881","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jtha.2025.10.007","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T17:14:11Z","timestamp":1761930851000},"page":"672-681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Frequency of, and prognostic factors for, residual thrombosis and complete veno-occlusion following anticoagulation for provoked venous thromboembolism in patients &lt;21 years: findings from the Kids-DOTT Multinational Trial"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1700-4804","authenticated-orcid":false,"given":"Rukhmi","family":"Bhat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjali","family":"Sharathkumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riten","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando F.","family":"Corrales-Medina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heleen","family":"van Ommen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihir","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Smita","family":"Dandekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maua","family":"Mosha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil A.","family":"Goldenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2025.10.007_bib1","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-3494","article-title":"Children\u2019s hospitals\u2019 solutions for patient safety collaborative impact on hospital-acquired harm","volume":"140","author":"Lyren","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.jtha.2025.10.007_bib2","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-054649","article-title":"The continued rise of venous thromboembolism across US children\u2019s hospitals","volume":"149","author":"O\u2019Brien","year":"2022","journal-title":"Pediatrics"},{"key":"10.1016\/j.jtha.2025.10.007_bib3","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.thromres.2011.08.006","article-title":"Health care expenditures associated with venous thromboembolism among children","volume":"129","author":"Boulet","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.10.007_bib4","doi-asserted-by":"crossref","first-page":"454S","DOI":"10.1378\/chest.08-0658","article-title":"Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Kearon","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2025.10.007_bib5","doi-asserted-by":"crossref","first-page":"e737S","DOI":"10.1378\/chest.11-2308","article-title":"Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Monagle","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2025.10.007_bib6","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1182\/bloodadvances.2018024786","article-title":"American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism","volume":"2","author":"Monagle","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.10.007_bib7","doi-asserted-by":"crossref","first-page":"955","DOI":"10.7326\/0003-4819-137-12-200212170-00008","article-title":"Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism","volume":"137","author":"Prandoni","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtha.2025.10.007_bib8","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1111\/j.1538-7836.2006.02120.x","article-title":"Post-treatment residual thrombus increases the risk of recurrent deep vein thrombosis and mortality","volume":"4","author":"Young","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.10.007_bib9","doi-asserted-by":"crossref","first-page":"577","DOI":"10.7326\/0003-4819-150-9-200905050-00003","article-title":"Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial","volume":"150","author":"Prandoni","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtha.2025.10.007_bib10","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.10.007_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13054-021-03457-0","article-title":"Incidence, prognostic factors, and outcomes of venous thromboembolism in critically ill patients: data from two prospective cohort studies","volume":"25","author":"Eck","year":"2021","journal-title":"Crit Care"},{"key":"10.1016\/j.jtha.2025.10.007_bib12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/rth2.12079","article-title":"Risk factors for recurrence in deep vein thrombosis patients following a tailored anticoagulant treatment incorporating residual vein obstruction","volume":"2","author":"Nagler","year":"2018","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.10.007_bib13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/s-0035-1544161","article-title":"The impact of residual thrombosis on the long-term outcome of patients with deep venous thrombosis treated with conventional anticoagulation","volume":"41","author":"Prandoni","year":"2015","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2025.10.007_bib14","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1538-7836.2004.00532.x","article-title":"Natural history of arterial and venous thrombosis in children treated with low molecular weight heparin: a longitudinal study by ultrasound","volume":"2","author":"Revel-Vilk","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.10.007_bib15","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.3324\/haematol.2010.026989","article-title":"Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors","volume":"95","author":"Goldenberg","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2025.10.007_bib16","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1203\/00006450-200006000-00013","article-title":"Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry","volume":"47","author":"Monagle","year":"2000","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jtha.2025.10.007_bib17","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1046\/j.1538-7836.2003.00465.x","article-title":"Pediatric venous thromboembolic disease in one single center: congenital prothrombotic disorders and the clinical outcome","volume":"1","author":"van Ommen","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.10.007_bib18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1001\/jama.2021.23182","article-title":"Effect of anticoagulant therapy for 6 weeks vs 3 months on recurrence and bleeding events in patients younger than 21 years of age with provoked venous thromboembolism: the Kids-DOTT randomized clinical trial","volume":"327","author":"Goldenberg","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2025.10.007_bib19","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jtha.2024.09.038","article-title":"Duration of anticoagulation for venous thromboembolism in pediatric patients: evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) trial outcomes at 2 years","volume":"23","author":"Goldenberg","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.10.007_bib20","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.jtha.2023.03.004","article-title":"Updated guidance for efficacy and safety outcomes for clinical trials in venous thromboembolism in children: communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis","volume":"21","author":"Whitworth","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.10.007_bib21","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/MPH.0000000000000920","article-title":"Six weeks versus 3 months of anticoagulant treatment for pediatric central venous catheter-related venous thromboembolism","volume":"39","author":"Smith","year":"2017","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jtha.2025.10.007_bib22","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jvsv.2017.12.059","article-title":"Presence and degree of residual venous obstruction on serial duplex imaging is associated with increased risk of recurrence and progression of infrainguinal lower extremity deep venous thrombosis","volume":"6","author":"Yoo","year":"2018","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"10.1016\/j.jtha.2025.10.007_bib23","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1055\/a-2059-4737","article-title":"Residual venous obstruction as an indicator of clinical outcomes following deep vein thrombosis: a management study","volume":"123","author":"Iding","year":"2023","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.10.007_bib24","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1182\/bloodadvances.2020002974","article-title":"Plasma fibrinolysis, inflammatory markers, and postthrombotic syndrome: preliminary findings from the Kids-DOTT Biobank","volume":"5","author":"Betensky","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.10.007_bib25","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/pbc.24840","article-title":"Health-related quality of life in children and young adults with post-thrombotic syndrome: results from a cross-sectional study","volume":"61","author":"Kumar","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtha.2025.10.007_bib26","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jtha.2023.01.004","article-title":"Functional impact of pediatric postthrombotic syndrome","volume":"21","author":"Bastas","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.10.007_bib27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jtha.2024.09.018","article-title":"Incidence and risk factors for postthrombotic syndrome in neonates and children in a single-center cohort study","volume":"23","author":"Klaassen","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.10.007_bib28","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1182\/blood-2016-03-704585","article-title":"Postthrombotic syndrome and other outcomes of lower extremity deep vein thrombosis in children","volume":"128","author":"Avila","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.10.007_bib29","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1016\/S2352-3026(20)30368-9","article-title":"Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b\/3, non-inferiority trial","volume":"8","author":"Halton","year":"2021","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtha.2025.10.007_bib30","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S2352-3026(19)30219-4","article-title":"Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial","volume":"7","author":"Male","year":"2020","journal-title":"Lancet Haematol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625006725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625006725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T07:21:45Z","timestamp":1778224905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783625006725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1538783625006725"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2025.10.007","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Frequency of, and prognostic factors for, residual thrombosis and complete veno-occlusion following anticoagulation for provoked venous thromboembolism in patients <21 years: findings from the Kids-DOTT Multinational Trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}